Martino Pedrani
Bellinzona, TI 6500, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743-745. http://dx.doi.org/10.1016/j.euo.2026.04.008.
Journal: European urology oncology
Published: June 30, 2026
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.
Journal: European urology oncology
Published: June 30, 2026
Hot flushes during ADT for prostate cancer - a clinical rationale for a neurokinin 3 receptor antagonist.
Journal: Nature reviews. Urology
Published: April 28, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
Journal: Drugs
Published: April 16, 2026
When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era.
Journal: European urology oncology
Published: April 02, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2025
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.
Journal: Journal of clinical medicine
Published: November 14, 2025
Beyond Menopause: Ending the Inequality-Why Men with Prostate Cancer Still Lack Therapies for Hot Flushes.
Journal: European urology
Published: November 12, 2025
Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysis.
Journal: European urology oncology
Published: November 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.
Journal: Cancers
Published: October 16, 2025
Last Updated: 09/26/2026